Patents by Inventor Kevin G. Connors

Kevin G. Connors has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140081076
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: November 25, 2013
    Publication date: March 20, 2014
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: Ernest G. Schutt, Kevin G. Connors, John Gillespie, JR., Peter Dayton
  • Publication number: 20140046125
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: October 24, 2013
    Publication date: February 13, 2014
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: John Gillespie, JR., Ryan J. Cahill, Kevin G. Connors, Peter Dayton, Carla Wiese
  • Publication number: 20140046124
    Abstract: Method and system for treating a patient using a compressible, pressure-attenuating device. According to one embodiment, the system is used to treat urinary tract disorders and can include one or more of an access device, a delivery device, a pressure-attenuating device, and a removal device. The access device may be used to create a passageway to an anatomical structure, such as the patient's bladder. The delivery device may be inserted through the passageway created by the access device and may be used to deliver the pressure-attenuating device to the anatomical structure. The removal device may be inserted through the passageway created by the access device and may be used to view the bladder and/or to capture, to deflate and to remove the pressure-attenuating device.
    Type: Application
    Filed: September 5, 2013
    Publication date: February 13, 2014
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: Ryan J. Cahill, Kevin G. Connors
  • Patent number: 8647349
    Abstract: Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures are disclosed. The system and devices provide simplified use and reduced risk of adverse events. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic. An intrauterine access end procedure system includes a mechanical distension element, to eliminate the need for liquid distension media at pressure sufficient to create a risk of intravasation.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: February 11, 2014
    Assignee: Hologic, Inc.
    Inventors: William H. Gruber, Ronald D. Adams, Kevin G. Connors, Geoffrey B. Pardo, James Daniel Cole, J. Christopher Flaherty
  • Patent number: 8574146
    Abstract: An implant for use in a human or animal body can include a flexible housing with an outer wall and having a chamber therein. The implant can have at least one high vapor pressure medium within the chamber. The at one high vapor pressure medium can have a combined vapor pressure equal to or greater than about the average value of the hydrostatic pressure of the implantation site plus the skin tension of the housing minus the gas tension of the dissolved gasses present at the implantation site.
    Type: Grant
    Filed: November 24, 2009
    Date of Patent: November 5, 2013
    Assignee: AttenueX Technologies, Inc.
    Inventors: John Gillespie, Jr., Kevin G. Connors, Ernest G. Schutt, Peter Dayton
  • Publication number: 20130289529
    Abstract: An implant delivery system can be configured to deliver an inflatable implant into a bladder via a urethra. The delivery system can comprise an elongate tubular body, an inflation tube and an implant decoupler. The tubular body can comprise a central lumen configured to hold an inflatable implant in an initial un-inflated state for delivery of the implant into the bladder. A method of use can include passing a distal tip of the elongate tubular body into the bladder. The implant can be inflated and released into the bladder.
    Type: Application
    Filed: June 24, 2013
    Publication date: October 31, 2013
    Inventors: Sheila Caira, John Gillespie, JR., Peter Dayton, Kevin G. Connors
  • Publication number: 20130267868
    Abstract: Measurement of a patient's leak point pressure in the bladder can be taken by a processor in communication with a pressure catheter in the bladder. When leakage occurs pressure data points can be recorded. In some embodiments, the peak pressure can be determined based on pressure data points measured during a set time just before receiving a clinician input indicative that leakage has occurred.
    Type: Application
    Filed: October 25, 2012
    Publication date: October 10, 2013
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Patent number: 8298132
    Abstract: Disclosed herein are methods of treating a patient with benign hypertrophy of the prostate, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration and attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change. In one embodiment, the attenuation device is advanced percutaneously into the bladder. In another embodiment, the attenuation device is positioned within the bladder to inhibit a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate.
    Type: Grant
    Filed: December 23, 2008
    Date of Patent: October 30, 2012
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Mathew T. Yurek
  • Publication number: 20120203262
    Abstract: An implant delivery system can be used to deliver an implant into a body. The implant delivery system can include an inflation tube and a tubular member surrounding the inflation tube. The inflation tube can be used to provide an inflation medium to the implant. The tubular member can have a distal tip and an opening spaced from the tip to allow the implant to be released through the opening into an anatomical structure within the body.
    Type: Application
    Filed: September 8, 2011
    Publication date: August 9, 2012
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: Kevin G. Connors, John Randall Liddicoat
  • Patent number: 8025064
    Abstract: Disclosed herein are methods of treating a patient, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration. The attenuation device is introduced into a treatment site. In one embodiment, the treatment site is a patient's eye. The volume of the attenuation devices changes in response to pressure changes in the treatment site and attenuates pressure changes in the eye.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: September 27, 2011
    Inventors: Kevin G Connors, Edward Bullister
  • Patent number: 8016740
    Abstract: A therapeutic device is provided. The therapeutic device can include a flexible housing and can be configured to be positioned within an anatomical structure. The therapeutic device can also include at least one high vapor pressure media having a vapor pressure greater than the pressure within the anatomical structure and a permeability of less than 1 ml/day at body temperature through said outer wall.
    Type: Grant
    Filed: June 1, 2009
    Date of Patent: September 13, 2011
    Assignee: Attenuex Technologies, Inc.
    Inventors: Kevin G. Connors, John Randall Liddicoat
  • Publication number: 20110054488
    Abstract: Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures are disclosed. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic. Distension is achieved mechanically, rather than with liquid distension media, thereby eliminating the risk of intravasation.
    Type: Application
    Filed: July 23, 2010
    Publication date: March 3, 2011
    Inventors: William H. Gruber, Ronald D. Adams, Kevin G. Connors, Geoffrey B. Pardo, James Daniel Cole, J. Christopher Flaherty
  • Publication number: 20100222802
    Abstract: An implant for use in a human or animal body can include a flexible housing with an outer wall and having a chamber therein. The implant can have at least one high vapor pressure medium within the chamber. The at one high vapor pressure medium can have a combined vapor pressure equal to or greater than about the average value of the hydrostatic pressure of the implantation site plus the skin tension of the housing minus the gas tension of the dissolved gasses present at the implantation site.
    Type: Application
    Filed: November 24, 2009
    Publication date: September 2, 2010
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: John Gillespie, JR., Kevin G. Connors, Ernest G. Schutt, Peter Dayton
  • Patent number: 7763033
    Abstract: Systems, methods, apparatus and devices for performing improved gynecologic and urologic procedures are disclosed. Patient benefit is achieved through improved outcomes, reduced pain, especially peri-procedural pain, and reduced recovery times. The various embodiments enable procedures to be performed outside the hospital setting, such as in a doctor's office or clinic. Distension is achieved mechanically, rather than with liquid distension media, thereby eliminating the risk of intravasation.
    Type: Grant
    Filed: September 7, 2007
    Date of Patent: July 27, 2010
    Assignee: Interlace Medical, Inc.
    Inventors: William H. Gruber, Ronald D. Adams, Kevin G. Connors, Geoffrey B. Pardo, James Daniel Cole, J. Christopher Flaherty
  • Patent number: 7691051
    Abstract: Disclosed herein is an attenuation device, comprising a flexible housing and a high vapor pressure media having a permeability of less than 1 ml/day at body temperature through the outer wall of the flexible housing. In one embodiment, the high vapor pressure media comprises perfluorooctylbromide. In another embodiment, the high vapor pressure media comprises perfluorohexane. In yet another embodiment, the high vapor pressure media comprises perfluorodecalin. Also disclosed herein is a method of treating a patient, comprising providing a compressible attenuation device and introducing within the attenuation device at least one high vapor pressure media.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: April 6, 2010
    Assignee: Cascade Ophthalmics, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Publication number: 20090240277
    Abstract: A therapeutic device is provided. The therapeutic device can include a flexible housing and can be configured to be positioned within an anatomical structure. The therapeutic device can also include at least one high vapor pressure media having a vapor pressure greater than the pressure within the anatomical structure and a permeability of less than 1 ml/day at body temperature through said outer wall.
    Type: Application
    Filed: June 1, 2009
    Publication date: September 24, 2009
    Applicant: ATTENUEX TECHNOLOGIES,INC.
    Inventors: Kevin G. Connors, John Randall Liddicoat
  • Publication number: 20090105527
    Abstract: Disclosed herein are methods of treating a patient with benign hypertrophy of the prostate, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration and attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change. In one embodiment, the attenuation device is advanced percutaneously into the bladder. In another embodiment, the attenuation device is positioned within the bladder to inhibit a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate.
    Type: Application
    Filed: December 23, 2008
    Publication date: April 23, 2009
    Applicant: ATTENUEX TECHNOLOGIES, INC.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Patent number: 7484510
    Abstract: Disclosed herein is an attenuation device comprising a flexible housing and a medium capable of transformation to inflate the housing from the first configuration to the second configuration. Also disclose herein are methods of treating a patient, comprising: providing a self-inflating expandable attenuation device, containing a medium which is transformable from a first, reduced volume to a second, expanded volume; positioning the attenuation device within the patient at a treatment site; and transforming the medium from the first volume to the second volume. In one embodiment, a self-inflating expandable attenuation device is used to treat glaucoma.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: February 3, 2009
    Assignee: Cascade Ophthalmics, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Patent number: 7470228
    Abstract: Disclosed herein are methods of treating a patient with benign hypertrophy of the prostate, comprising providing a compressible attenuation device that is moveable from a first, introduction configuration to a second, implanted configuration and attenuating a pressure change within the bladder by reversibly changing the volume of the attenuation device in response to the pressure change. In one embodiment, the attenuation device is advanced transurethrally into the bladder. In another embodiment, the attenuation device is positioned within the bladder to inhibit a decrease in compliance of the bladder wall as a consequence of the benign hypertrophy of the prostate.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: December 30, 2008
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek
  • Patent number: 7374532
    Abstract: Disclosed herein is an attenuation device, comprising a flexible housing and a high vapor pressure media having a vapor pressure approximately equal to the intravesical pressure of the bladder and a permeability of less than 1 ml/day at body temperature through the outer wall of the flexible housing. In one embodiment, the high vapor pressure media comprises perfluorooctylbromide. In another embodiment, the high vapor pressure media comprises perfluorohexane. In yet another embodiment, the high vapor pressure media comprises perfluorodecalin. Also disclosed herein is a method of treating a patient, comprising providing a compressible attenuation device and introducing within the attenuation device at least one high vapor pressure media.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: May 20, 2008
    Assignee: AttenueX Technologies, Inc.
    Inventors: Kevin G. Connors, William L. Pintauro, Sheila K. Wallin, John T. Kilcoyne, Hung H. Cao, Khoi M. Nguyen, Matthew T. Yurek